The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)
社区研究:环境劣势与阿尔茨海默病及相关痴呆症 (ADRD)
基本信息
- 批准号:10803585
- 负责人:
- 金额:$ 349.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmyloidAnimal ModelAreaAtlasesAutopsyBackBehaviorBiologicalBiological ProcessBiological Specimen BanksBrainCaliforniaClinicalCodeCognitiveCollaborationsConsentDataDementiaDevelopmentDiagnosisDisadvantagedDiseaseDisparityDistalDoseEducationEmploymentEthnic OriginEvaluationExposure toFoundationsFundingFutureGeographyGoalsHealthHealth behaviorHousingHumanImpaired cognitionIncomeIndividualIndividual AdjustmentIndustryInfrastructureInterdisciplinary StudyLife Cycle StagesLinkMagnetic Resonance ImagingMediatingMediatorMethodologyMissionNational Institute on AgingNeighborhoodsNerve DegenerationOutcomeParticipantPartner in relationshipPathologicPathway interactionsPersonsPhenotypePopulations at RiskPositron-Emission TomographyPovertyPrevalenceRaceRecording of previous eventsResearchResearch DesignResearch SupportRiskRisk AssessmentRisk FactorsSamplingScienceStandardizationSurveysTimeTissuesUniversitiesWisconsinWorkburden of illnesscognitive changecognitive functioncomorbiditydeprivationdosageeffective interventionethnic minorityimprovedindexingmortalityneighborhood associationneighborhood disadvantageneuroimagingneuropathologyneurophysiologynovelnovel therapeutic interventionnovel therapeuticsprospectivepublic databaseracial minorityrandomized trialsecondary outcomesexsocialsocial health determinantssocioeconomic disadvantagesocioeconomicssociologisttau Proteinstheoriestherapy development
项目摘要
Dementia due to Alzheimer’s disease and related dementias (ADRD) disproportionately impacts racial/ethnic
minorities and the socioeconomically disadvantaged. Development of effective interventions require mechanistic
understanding of distal fundamental forces, including socioeconomic context (i.e. “neighborhood disadvantage”
or the social determinants of health of a given area), that put people at “risk for [more proximal] risks” such as
individual-level income, education, health behaviors and comorbidity. Prior research supports that contextual
disadvantage is modifiable and interacts with biological processes to produce disease, yet little is known of its
impact on ADRD. Towards this, we created validated quantifications of neighborhood disadvantage for the full
US. This Area Deprivation Index (ADI) incorporates poverty, education, housing and employment indicators;
predicts disparity-related health outcomes; and is freely shared through our public platform (the Neighborhood
Atlas). We have validated survey and public data-based residential history tracing methodologies that establish
dosage and timing of neighborhood disadvantage exposure across a life-course for both living and deceased
persons. We have demonstrated that even after adjustment for individual risk factors, neighborhood
disadvantage is strongly associated with cognitive function, neurodegeneration shown on MRI, and post-mortem
AD plaque neuropathology. However, our current sample is lacking in geographic diversity and is of insufficient
size to conduct a more robust multi-factor phenotypic risk assessment of social-biological interactions and their
mechanisms; a necessary foundation towards developing new therapeutic intervention. This proposal employs
collaboration with 22 Alzheimer’s Disease Research Centers (ADRC) and their existing cognitive, neuroimaging
and neuropathology data. We take on the substantial work to create detailed residential histories for each ADRC
subject (N~9,234 living, N~10,469 brain bank) to establish a dosage and timing of neighborhood disadvantage
exposure across each life-course. Hypothesis: Larger and earlier exposures to neighborhood disadvantage will
predict lower cognitive function, faster cognitive decline and greater disease burden including AD neuropathology
among the targeted sample. Aim 1: Determine the impact of the cumulative dose and timing of neighborhood
disadvantage exposure (indexed by ADI), on cognitive function and change over time; Aim 2: on AD-specific
markers indexed by neuroimaging (amyloid and tau PET) and the secondary outcome of volumetric MRI; and
Aim 3: on neuropathologic tissue features and diagnosis. Aim 4: Using existing ADRC data and newly collected
survey data, define the extent to which individual race/ethnicity, age, sex, income, education, comorbidity and
health-behaviors mediate these relationships. The proposed project, if funded, will be the largest study of its kind
on social determinants of health in the context of AD. Successful completion will result in the development of a
novel collaborative infrastructure of contextual exposure for future social-biological phenotypic evaluation,
providing a potential pathway to new therapeutics, and directly responsive to the NIA mission.
由于阿尔茨海默氏病和相关痴呆症(ADRD)导致的痴呆症对种族/种族的影响不成比例
少数民族和社会经济处于不利地位。开发有效干预需要机械
了解远端基本力量,包括社会经济背景(即“邻里灾难”)
或给定地区健康的社会决定者),使人们处于“有[更近端]风险的风险”,例如
个人级别的收入,教育,健康行为和合并症。先前的研究支持这种背景
劣势是可修改的,并且与生物学过程相互作用以产生疾病,但知之甚少
对ADRD的影响。为此,我们创建了对邻里灾难的经过验证的量化
我们。该地区剥夺指数(ADI)纳入了贫困,教育,住房和就业指标;
预测与差异相关的健康结果;并通过我们的公共平台(社区)自由共享
地图集)。我们已经验证了建立的调查和基于公共数据的居民历史记录追踪方法
生命和死者的生命过程中邻里灾难暴露的剂量和时机
人。我们已经证明,即使调整了个人风险因素,社区
缺点与认知功能,MRI上显示的神经退行性和验尸密切相关
AD斑块神经病理学。但是,我们目前的样本缺乏地理多样性,并且不足
进行更强大的多因素表型风险评估社会生物互动及其的大小
机制;发展新的治疗干预措施的必要基础。该提案员工
与22个阿尔茨海默氏病研究中心(ADRC)及其现有的认知,神经影像合作
和神经病理学数据。我们从事大量工作,为每个ADRC创建详细的居民历史
主题(N〜9,234 Living,N〜10,469 Brain Bank)建立剂量和邻里灾难时机
每个生命过程中的暴露。假设:对邻里灾难的更大和更早的暴露将
预测较低的认知功能,更快的认知能力下降和更大的疾病燃烧包括AD神经病理
在目标样本中。目标1:确定累积剂量和邻里时间的影响
缺点暴露(由ADI索引),关于认知功能和随着时间的变化; AIM 2:在广告中
由神经成像(淀粉样蛋白和Tau PET)和体积MRI的次要结果索引的标记;和
目标3:对神经病理组织特征和诊断。 AIM 4:使用现有的ADRC数据并新收集
调查数据,定义个人种族/种族,年龄,性别,收入,教育,合并症的程度
健康行为调解了这些关系。拟议的项目(如果资助)将是同类项目的最大研究
关于在AD背景下健康的社会决定者。成功完成将导致发展
对未来社会生物表型评估的上下文暴露的新型协作基础设施,
提供了通往新疗法的潜在途径,并直接响应了NIA任务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara Brigitta Bendlin其他文献
Barbara Brigitta Bendlin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara Brigitta Bendlin', 18)}}的其他基金
ß-hydroxybutyrate inhibition of pathology in Alzheimer's disease
α-羟基丁酸对阿尔茨海默病病理学的抑制作用
- 批准号:
10739679 - 财政年份:2023
- 资助金额:
$ 349.4万 - 项目类别:
Administrative Supplement to Establish National Exposome Alzheimer's Disease and Related Dementias (ADRD) Infrastructure (Expo-AD)
建立国家阿尔茨海默氏病和相关痴呆症 (ADRD) 基础设施 (Expo-AD) 的行政补充
- 批准号:
10658250 - 财政年份:2021
- 资助金额:
$ 349.4万 - 项目类别:
The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)
社区研究:环境劣势与阿尔茨海默病及相关痴呆症 (ADRD)
- 批准号:
10361428 - 财政年份:2021
- 资助金额:
$ 349.4万 - 项目类别:
The Neighborhoods Study: Contextual Disadvantage and Alzheimer’s Disease and Related Dementias (ADRD)
社区研究:环境劣势与阿尔茨海默病及相关痴呆症 (ADRD)
- 批准号:
10580795 - 财政年份:2021
- 资助金额:
$ 349.4万 - 项目类别:
SV2A PET imaging in Alzheimer's Disease
SV2A PET 成像在阿尔茨海默病中的应用
- 批准号:
9919489 - 财政年份:2018
- 资助金额:
$ 349.4万 - 项目类别:
SV2A PET imaging in Alzheimer's Disease
SV2A PET 成像在阿尔茨海默病中的应用
- 批准号:
10403978 - 财政年份:2018
- 资助金额:
$ 349.4万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 349.4万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 349.4万 - 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 349.4万 - 项目类别: